This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunot
โฆ LIBER โฆ
Immunotherapy using fusions of autologous dendritic cells and tumor cells showed effective clinical response in a patient with advanced gastric carcinoma
โ Scribed by Sadamu Homma; Kazuo Matai; Masaki Irie; Tsuneya Ohno; Donald Kufe; Gotaro Toda
- Publisher
- Springer Japan
- Year
- 2003
- Tongue
- English
- Weight
- 446 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
A phase II study of adoptive immunothera
โ
Daniel H. Palmer; Rachel S. Midgley; Noweeda Mirza; Elizabeth E. Torr; Forhad Ah
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 286 KB
A pilot clinical trial of vaccination wi
โ
Gee-Chen Chang; Haw-Chang Lan; Shin-Hun Juang; Yu-Chen Wu; Hui-Chen Lee; Yi-Mei
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 310 KB
๐ 1 views
Response assessment classification in pa
โ
Lawrence H. Schwartz; Madhu Mazumdar; Liang Wang; Alex Smith; Stephanie Marion;
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 200 KB
## Abstract ## BACKGROUND The objective of the current study was to evaluate the effect on response assessment classification in patients with metastatic renal cell carcinoma (RCC) using unidimensional (Response Evaluation Criteria in Solid Tumors) and bidimensional (World Health Organization) cri